Cargando…
B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171700/ http://dx.doi.org/10.1097/01.HS9.0000936104.91195.3e |
| _version_ | 1785039478870507520 |
|---|---|
| author | Musto, P. Minnema, M.C. Roeloffzen, W.W.H. Capra, A. van der Holt, B. Juul Vangsted, A. Broyl, A. Schjesvold, F. Lund, T. Silkjaer, T. Benjamin, R. Grasso, M. Lung Wu, K. Caers, J. Cavo, M. Hájek, R. Bruno, B. Gadisseur, A. Pietrantuono, G. Offidani, M. Pour, L. Sonneveld, P. Boccadoro, M. van de Donk, N. |
| author_facet | Musto, P. Minnema, M.C. Roeloffzen, W.W.H. Capra, A. van der Holt, B. Juul Vangsted, A. Broyl, A. Schjesvold, F. Lund, T. Silkjaer, T. Benjamin, R. Grasso, M. Lung Wu, K. Caers, J. Cavo, M. Hájek, R. Bruno, B. Gadisseur, A. Pietrantuono, G. Offidani, M. Pour, L. Sonneveld, P. Boccadoro, M. van de Donk, N. |
| author_sort | Musto, P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10171700 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101717002023-05-11 B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS Musto, P. Minnema, M.C. Roeloffzen, W.W.H. Capra, A. van der Holt, B. Juul Vangsted, A. Broyl, A. Schjesvold, F. Lund, T. Silkjaer, T. Benjamin, R. Grasso, M. Lung Wu, K. Caers, J. Cavo, M. Hájek, R. Bruno, B. Gadisseur, A. Pietrantuono, G. Offidani, M. Pour, L. Sonneveld, P. Boccadoro, M. van de Donk, N. Hemasphere Best Abstracts - Oral Presentations Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171700/ http://dx.doi.org/10.1097/01.HS9.0000936104.91195.3e Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Best Abstracts - Oral Presentations Musto, P. Minnema, M.C. Roeloffzen, W.W.H. Capra, A. van der Holt, B. Juul Vangsted, A. Broyl, A. Schjesvold, F. Lund, T. Silkjaer, T. Benjamin, R. Grasso, M. Lung Wu, K. Caers, J. Cavo, M. Hájek, R. Bruno, B. Gadisseur, A. Pietrantuono, G. Offidani, M. Pour, L. Sonneveld, P. Boccadoro, M. van de Donk, N. B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS |
| title | B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS |
| title_full | B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS |
| title_fullStr | B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS |
| title_full_unstemmed | B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS |
| title_short | B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS |
| title_sort | b03 carfilzomib and lenalidomide for primary plasma cell leukemia: final results of the prospective phase 2 emn12/hovon-129 study for patients aged ≥66 years |
| topic | Best Abstracts - Oral Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171700/ http://dx.doi.org/10.1097/01.HS9.0000936104.91195.3e |
| work_keys_str_mv | AT mustop b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT minnemamc b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT roeloffzenwwh b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT capraa b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT vanderholtb b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT juulvangsteda b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT broyla b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT schjesvoldf b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT lundt b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT silkjaert b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT benjaminr b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT grassom b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT lungwuk b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT caersj b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT cavom b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT hajekr b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT brunob b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT gadisseura b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT pietrantuonog b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT offidanim b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT pourl b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT sonneveldp b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT boccadorom b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years AT vandedonkn b03carfilzomibandlenalidomideforprimaryplasmacellleukemiafinalresultsoftheprospectivephase2emn12hovon129studyforpatientsaged66years |